Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that its CSR Data Book 2016 received the Good Performance Prize in the Environmental Report Section of the 20th Environmental Communication Awards. It is co-sponsored by Japan’s Ministry of the Environment and the Global Environmental Forum*. Takeda received the Excellence Prize in 2011, Good Performance Prize in 2014 and 2015, and this is the third year in a row and forth time overall to receive a prize in this award.
The Environmental Communication Awards recognize outstanding environmental reports and environmental activity reports. The purpose is to promote companies' efforts in environmental management and communication, and to dispatch quality non-financial information by using a new information disclosure framework. This year marks the 20th anniversary of the Environmental Communication Awards.
The prize was awarded in recognition of Takeda's comprehensive description of its efforts such as specifying its materiality by referring to Sustainable Development Goals (SDGs) as well as assessing wide range society's demands including investors'. Another effort is executing initiatives in collaboration with its overseas subsidiaries and suppliers proactively incorporating advanced international framework such as SDGs.
Takeda’s management mission is to strive towards better health and a brighter future for people worldwide through leading innovation in medicine. In line with this mission, Takeda puts patients at the center of every activity and believes that CSR is the foundation of any pharmaceutical business. As a pharmaceutical company dedicated to improving people’s lives, Takeda remains committed to the fulfillment of its social responsibilities in response to the needs of global society, and aims to produce even better reports in the future with the interests of all its stakeholders firmly in mind.
* The Global Environmental Forum is a non-profit environmental organization founded in 1990 to conduct scientific surveys and research on global environmental issues, disseminate and promote such issues to the public, and make policy recommendations.
For Takeda, CSR is rooted in putting the patient in the center and operating a pharmaceutical business that creates outstanding products. In addition, we strive to maintain and improve sound business processes, and to engage in activities to promote a sustainable society as a good corporate citizen. In doing so, we are implementing a model of value creation and preservation through CSR. This will help us to build trust with society, reinforce our reputation, and further develop the pharmaceutical business. For more information, visit http://www.takeda.com/csr/index.html.
Since fiscal 2006, Takeda has conducted integrated reporting, incorporating non-financial information about our initiatives on human rights, the environment, and communities, etc., in addition to financial information. Based on this, we have been publishing integrated annual reports. Since fiscal 2009, we have published the CSR Data Book as a supplementary report to the integrated annual report. In this CSR Data Book, we have referred to the international framework for integrated reporting of the IIRC, the United Nations Global Compact Advanced level criteria, and GRI’s Fourth Generation of Sustainability Reporting Guidelines (G4) to create a report targeting a broad range of stakeholders. For more information, visit http://www.takeda.com/csr/reports/.
+81 (0) 3-3278-2417